Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
Chun‐Yu Liu(Division of Materials Science and Engineering), Kuen‐Feng Chen(National Taiwan University), Duen‐Shian Wang(Taipei Veterans General Hospital), Ling‐Ming Tseng(National Yang Ming Chiao Tung University), Chia‐Chi Hsu(National Taiwan University Hospital), Pei‐Yi Chu(Fu Jen Catholic University), Chia‐Han Lee(National Institutes of Health), Ming‐Huang Chen(National Yang Ming Chiao Tung University), Yi‐Ting Chen(First Affiliated Hospital Zhejiang University), Ming-Hung Hu(Fu Jen Catholic University), Wen-Chun Tsai(Taipei Veterans General Hospital), Chun‐Teng Huang(Sanford Burnham Prebys Medical Discovery Institute), Chung-Wai Shiau(National Yang Ming Chiao Tung University), Chia-Jung Hsu(National Yang Ming Chiao Tung University)
Cited by 5
Related Papers
The genome sequence of the orchid Phalaenopsis equestris
|Nature Genetics|2014|511
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
|International Journal of Molecular Sciences|2017|386
Role of mitochondrial dysfunction in cancer progression
|Experimental Biology and Medicine|2016|313
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
|The Lancet. Gastroenterology & hepatology|2024|245